Quantifying transmission of norovirus during an outbreak

Epidemiology

Volumn 23, Issue 2, 2012, Pages 277-284

  Heijne, Janneke C M ^a   Rondy, Marc ^b,c   Verhoef, Linda ^b   Wallinga, Jacco ^b,d   Kretzschmar, Mirjam ^b,d   Low, Nicola ^a   Koopmans, Marion ^b,e   Teunis, Peter F M ^b,f  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARTHEL INDEX; CLINICAL ARTICLE; EPIDEMIC; HEALTH CARE PERSONNEL; HUMAN; NETHERLANDS; NOROVIRUS; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS TRANSMISSION; WARD;

CALICIVIRIDAE INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; GASTROENTERITIS; HOSPITALS, PSYCHIATRIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; NETHERLANDS; NOROVIRUS;

EID: 84856871988     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182456ee6     Document Type: Article

References (33)

1. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med. 2009;361:1776-1785.
2. Phillips G, Tam CC, Conti S, et al. Community incidence of norovirusassociated infectious intestinal disease in England: Improved estimates using viral load for norovirus diagnosis. Am J Epidemiol. 2010;171: 1014-1022.
3. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: A prospective cohort study. Clin Infect Dis. 2002; 35:246-253. (Pubitemid 34800271)
4. Rondy M, Koopmans M, Rotsaert C, et al. Norovirus disease associated with excess mortality and use of statins: A retrospective cohort study of an outbreak following a pilgrimage to Lourdes. Epidemiol Infect. 2011; 139:453-463.
5. Ball JM, Graham DY, Opekun AR, Gilger MA, Guerrero RA, Estes MK. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study. Gastroenterology. 1999;117:40-48. (Pubitemid 29297618)
6. LoBue AD, Lindesmith L, Yount B, et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine. 2006;24:5220-5234. (Pubitemid 43818189)
7. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol. 2003;108:241-247. (Pubitemid 37117370)
8. Kirking HL, Cortes J, Burrer S, et al. Likely transmission of norovirus on an airplane, October 2008. Clin Infect Dis. 2010;50:1216-1221.
9. Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect. 2000;124:481-487. (Pubitemid 30623865)
10. Teunis PF, Moe CL, Liu P, et al. Norwalk virus: How infectious is it? J Med Virol. 2008;80:1468-1476. (Pubitemid 351897421)
11. Evans MR, Meldrum R, Lane W, et al. An outbreak of viral gastroenteritis following environmental contamination at a concert hall. Epidemiol Infect. 2002;129:355-360. (Pubitemid 35243764)
12. Siebenga JJ, Vennema H, Renckens B, et al. Epochal evolution of GGII. norovirus capsid proteins from 1995 to 2006. J Virol. 2007;81:9932-9941. (Pubitemid 350067696)
13. Siebenga JJ, Vennema H, Zheng DP, et al. Norovirus illness is a global problem: Emergence and spread of norovirus GII. 4 variants, 2001-2007. J Infect Dis. 2009;200:802-812.
14. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, Koopmans M. Phylodynamic reconstruction reveals norovirus GII. 4 epidemic expansions and their molecular determinants. PLoS Pathog. 2010;6:e1000884.
15. Heijne JC, Teunis P, Morroy G, et al. Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis. 2009;15: 24-30.
16. Friesema IH, Vennema H, Heijne JC, et al. Differences in clinical presentation between norovirus genotypes in nursing homes. J Clin Virol. 2009;46:341-344.
17. Vivancos R, Sundkvist T, Barker D, Burton J, Nair P. Effect of exclusion policy on the control of outbreaks of suspected viral gastroenteritis: Analysis of outbreak investigations in care homes. Am J Infect Control. 2010;38:139-143.
18. Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DW. Clinical manifestation of norovirus gastroenteritis in healthcare settings. Clin Infect Dis. 2004;39:318-324. (Pubitemid 39050478)
19. van Asten L, Siebenga J, van den Wijngaard C, et al. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology. 2011;22:336-343.
20. Friesema IH, Vennema H, Heijne JC, et al. Norovirus outbreaks in nursing homes: The evaluation of infection control measures. Epidemiol Infect. 2009;137:1722-1733.
21. Wyklicky H, Skopec M. Ignaz Philipp Semmelweis, the prophet of bacteriology. Infect Control. 1983;4:367-370. (Pubitemid 14071657)
22. Eveillard M, Kouatchet A, Rigaud A, et al. Association between an index of consumption of hand-rub solution and the incidence of acquired meticillin-resistant Staphylococcus aureus in an intensive care unit. J Hosp Infect. 2009;71:283-285.
23. Nicolau DV Jr., Kith G, Oshmyansky A. Evidence for a simple linear relationship between MRSA rates and hand-washing compliance. J Hosp Infect. 2010;75:140-141.
24. Talon D, Thouverez M, Bertrand X. Is there a threshold above which hand-rub solution consumption is efficient for decreasing MRSA incidence? J Hosp Infect. 2009;72:178-179.
25. Cauchemez S, Boelle PY, Thomas G, Valleron AJ. Estimating in real time the efficacy of measures to control emerging communicable diseases. Am J Epidemiol. 2006;164:591-597. (Pubitemid 44412788)
26. Cowling BJ, Lau MS, Ho LM, et al. The effective reproduction number of pandemic influenza: Prospective estimation. Epidemiology. 2010;21: 842-846.
27. Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol. 2004;160:509-516. (Pubitemid 39215626)
28. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J. 1965;14:61-65.
29. Kuk AY, Ma S. The estimation of SARS incubation distribution from serial interval data using a convolution likelihood. Stat Med. 2005;24: 2525-2537. (Pubitemid 41093929)
30. Sukhrie FH, Teunis P, Beersma MF, et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis. In press.
31. Mattner F, Mattner L, Borck HU, Gastmeier P. Evaluation of the impact of the source (patient versus staff) on nosocomial norovirus outbreak severity. Infect Control Hosp Epidemiol. 2005;26:268-272. (Pubitemid 40445085)
32. Johnston CP, Qiu H, Ticehurst JR, et al. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis. 2007; 45:534-540. (Pubitemid 47342395)
33. Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among healthcare workers in low-And middle-income countries: A systematic review. PLoS Med. 2006;3:e494.